Cytoplasmic DNA in cancer cells: Several pathways that potentially limit DNase2 and TREX1 activities
Author:
- 27 April 2022
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1869 (8) , 119278
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- Mitochondrial DNA that escapes from autophagy causes inflammation and heart failureNature, 2012
- The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1Nature Immunology, 2010
- Emerging roles of the host defense peptide LL‐37 in human cancer and its potential therapeutic applicationsInternational Journal of Cancer, 2010
- Three prime exonuclease I (TREX1) is Fos/AP-1 regulated by genotoxic stress and protects against ultraviolet light and benzo(a)pyrene-induced DNA damageNucleic Acids Research, 2010
- Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelementsGene, 2009
- TREX1 acts in degrading damaged DNA from drug-treated tumor cellsDNA Repair, 2009
- Trex1 Prevents Cell-Intrinsic Initiation of AutoimmunityCell, 2008
- Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosusNature Genetics, 2007
- A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupusJournal of Molecular Medicine, 2007
- A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNANature Immunology, 2005